The German Covid-19 vaccine manufacturer BioNTech has a complex network of manufacturing capabilities in Europe and there is also the Pfizer network in the United States.
Even if the coronavirus has mutated, German vaccine manufacturer BioNTech still believes that it is highly likely it can be combatted effectively. Company boss Ugur Sahin is considering new production facilities for the vaccine so that orders can be delivered earlier.
3 weeks ago
We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy.AcceptPrivacy